EUVIMEDEUVIMED entdecken
Crossref

Allogeneic stem cell transplantation remains an effective therapeutic option for patients with relapsed/refractory Hodgkin lymphoma: a Polish single-center retrospective analysis

Jagoda Tryc-Szponder, Barbara Więckowska, Bastian Von Tresckow, Lidia Gil

Acta Haematologica Polonica · 29.10.2026 · 57 (5) · 371-379

DOI: 10.5603/ahp.113063 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Haematologica Polonica, online erschienen am 29.10.2026. Verfasst von Jagoda Tryc-Szponder und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Tryc-Szponder, J., Więckowska, B., Tresckow, B. V., & Gil, L. (2026). Allogeneic stem cell transplantation remains an effective therapeutic option for patients with relapsed/refractory Hodgkin lymphoma: a Polish single-center retrospective analysis. Acta Haematologica Polonica, 57(5), 371-379. https://doi.org/10.5603/ahp.113063

Vancouver

Tryc-Szponder J, Więckowska B, Tresckow BV, Gil L. Allogeneic stem cell transplantation remains an effective therapeutic option for patients with relapsed/refractory Hodgkin lymphoma: a Polish single-center retrospective analysis. Acta Haematologica Polonica. 2026;57(5):371-379. doi:10.5603/ahp.113063

BibTeX
@article{TrycSzponder2026,
  author = {Tryc-Szponder, Jagoda and Więckowska, Barbara and Tresckow, Bastian Von and Gil, Lidia},
  title = {Allogeneic stem cell transplantation remains an effective therapeutic option for patients with relapsed/refractory Hodgkin lymphoma: a Polish single-center retrospective analysis},
  journal = {Acta Haematologica Polonica},
  year = {2026},
  volume = {57},
  number = {5},
  pages = {371--379},
  doi = {10.5603/ahp.113063}
}
Kostenlos starten →